Ban Randy 4

Accession 0001104659-24-090984

CIK 0001609550other

View on SEC.gov Company Profile

Filed

Aug 18, 8:00 PM ET

Accepted

Aug 19, 8:14 PM ET

Size

30.2 KB

Accession

0001104659-24-090984

Insider Transaction Report

Form 4

Period: 2024-08-15

Inspire Medical Systems, Inc.INSP

Ban Randy

See Remarks

Transactions

Exercise/Conversion
Common Stock
2024-08-15$42.15/sh+16,139$680,259→ 19,195 total
Sale
Common Stock
2024-08-15$189.06/sh−776$146,711→ 18,419 total
Sale
Common Stock
2024-08-15$191.92/sh−2,072$397,658→ 14,688 total
Sale
Common Stock
2024-08-15$192.60/sh−1,150$221,490→ 13,538 total
Sale
Common Stock
2024-08-15$194.91/sh−2,350$458,039→ 3,056 total
Sale
Common Stock
2024-08-16$187.10/sh−900$168,390→ 7,017 total
Sale
Common Stock
2024-08-16$188.66/sh−3,066$578,432→ 3,951 total
Sale
Common Stock
2024-08-16$189.64/sh−895$169,728→ 3,056 total
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-15−16,139→ 4,861 total
Exercise: $42.15Exp: 2028-12-18→ Common Stock (16,139 underlying)
Exercise/Conversion
Stock Option (Right to Buy)
2024-08-16−4,861→ 0 total
Exercise: $42.15Exp: 2028-12-18→ Common Stock (4,861 underlying)
Sale
Common Stock
2024-08-15$190.20/sh−1,659$315,542→ 16,760 total
Sale
Common Stock
2024-08-15$193.92/sh−8,132$1,576,957→ 5,406 total
Exercise/Conversion
Common Stock
2024-08-16$42.15/sh+4,861$204,891→ 7,917 total

Holdings

Common Stock
(indirect: By son)
167
Common Stock
(indirect: By daughter)
166

Footnotes (11)

[F1]Includes 27 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated February 27, 2024.
[F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.26 to $189.855. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F11]The option is fully vested and exercisable.
[F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.995 to $189.285. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.08 to $190.845. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.225 to $192.18. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.26 to $193.22. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.4 to $194.32. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.81 to $195.15. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.90 to $187.71. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
[F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.255 to $189.24. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote .

Documents

1 file

4
tm2422088-1_4seq1.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Inspire Medical Systems, Inc.

CIK 0001609550

→

Entity typeother

Related Parties

filerCIK 0001737127

Filing Metadata

Form type: 4
Filed: Aug 18, 8:00 PM ET
Accepted: Aug 19, 8:14 PM ET
Size: 30.2 KB

View on SEC.gov